BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea · Delayed Price · Currency is KRW 9,710.00
-140.00 (-1.42%)
At close: Jun 5, 2026
BIO-FD&C Market Cap
BIO-FD&C has a market cap or net worth of 84.44 billion as of June 5, 2026. Its market cap has decreased by -34.44% in one year.
Market Cap
84.44B
Enterprise Value
31.03B
Revenue
18.85B
Ranking
n/a
PE Ratio
13.37
Stock Price
9,710.00
Market Cap Chart
Since February 21, 2022, BIO-FD&C's market cap has decreased from 193.04B to 84.44B, a decrease of -56.26%. That is a compound annual growth rate of -17.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 84.44B | -38.54% |
| Dec 30, 2025 | 137.39B | 14.33% |
| Dec 30, 2024 | 120.17B | -2.12% |
| Dec 28, 2023 | 122.78B | -16.94% |
| Dec 29, 2022 | 147.83B | -23.42% |
| Feb 21, 2022 | 193.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovMetaPharma | 100.16B |
| QuadMedicine | 94.38B |
| Choong Ang Vaccine Laboratory | 87.87B |
| CTCBIO | 78.30B |
| Naturalendo Tech | 75.78B |
| SunBio,Inc. | 75.72B |
| KoBioLabs | 73.40B |
| AriBioLab | 69.58B |